BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210511
DTEND;VALUE=DATE:20210514
DTSTAMP:20260515T181258
CREATED:20210208T104245Z
LAST-MODIFIED:20210208T104245Z
UID:28869-1620691200-1620950399@www.pharmajournalist.com
SUMMARY:Manufacturing Assets and Facility Management in Pharma Summit 2021
DESCRIPTION:Manufacturing Assets and Facility Management in Pharma Summit returns in 2021. Taking place virtually this May 11-13\, a must attend event to help modernize your facility and revitalize your asset management strategies. Join this cutting-edge discussion and network with engineering\, maintenance and manufacturing facilities leaders. \nTo know more about Manufacturing Assets and Facility Management in Pharma Summit 2021 please click here.
URL:https://www.pharmajournalist.com/event/manufacturing-assets-and-facility-management-in-pharma-summit-2021/
LOCATION:Virtual Conference
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210512
DTEND;VALUE=DATE:20210514
DTSTAMP:20260515T181258
CREATED:20200108T084240Z
LAST-MODIFIED:20200604T152104Z
UID:23563-1620777600-1620950399@www.pharmajournalist.com
SUMMARY:Injectable Drug Delivery 2021
DESCRIPTION:Assessing the innovations in formulations and devices for enhanced injectable delivery  \nSMi Group is pleased to announce the third annual Injectable Drug Delivery conference\, which will be held in London on the 12th and 13th May 2021. \nPart of Europe’s leading Injectable conference series\, Injectable Drug Delivery will assess innovations in drug product formulation and biologics\, innovations in device design\, quality management and connectivity for enhanced subcutaneous delivery. \n \nWith rapid developments in the parenteral space\, the injectable drug delivery market is set to reach USD 902.3 billion by 2027\, with an increased focus on patient centricity during DDC development and innovations in device development\, including new therapeutic applications such as the delivery of siRNA. This year’s event will focus on advances in drug product formulation and innovations of device design and development to aid delivery. \nFurthermore\, the conference will assess the evolving regulatory environment of injectable drug delivery with industry and regulatory representatives presenting updates on current guidelines. \nThe two-day agenda also offers peer-to-peer networking with Global Product Managers\, Device Testing Managers\, Senior Device Engineers\, Heads of Device Development\, Heads of Formulation and Drug Process Development\, and many more. \nThe benefits of attending: \nThis conference offers a chance to learn about innovative injectable drug delivery systems with industrial insights on the following: \n\nDELVE into the latest work in complex formulation for subcutaneous delivery\nBENCHMARK against leading pharma companies working to enhance device design and development\nUNDERSTAND the regulatory environment of the injectables space from leading regulatory and industry advisors\nENGAGE in industry case studies on design controls\, human factors and parenteral formulation\nEXPLORE advances in connectivity and human factors key learnings in two pre-conference workshops\n\nWho should attend: \nExecutives\, Directors\, VPs\, Heads\, Principals\, Managers\, Scientists\, Researchers of: \n\nAutoinjectors\nWearables\nDevice Engineering\nHuman Factors\nCMC\nInjectables\nSterile Manufacturing\nPackaging\nRegulatory Affairs\n\nFeatured Speakers: \n\nAlexander Zuern\, Device testing manager\, Novartis International AG\nAndrew Warrington\, Project Leader & Patient Advocate\, Novartis\nBenjamin Werner\, Scientist\, Boehringer Ingelheim Pharma GmbH & Co. KG\nBjorg K Hunter\, Regulatory Manager\, Devices\, GSK\nBlake Green\, Senior Manager Regulatory Affairs\, Amgen\nCamille Dagallier\, Formulation and Drug Process Development Senior Scientist\, Sanofi\nChristopher Muenzer\, Senior Device Technology Manager\, Novartis\nJoel Richard\, Head of Technical & Pharmaceutical Operations\, MedinCell\nMark Palmer\, Scientific Leader\, Biopharm Device Engineering\, GSK\nRebecca Moses\, Director\, Core Human Factors Inc.\nRupal Nguyen\, Principal Engineer\, Allergan\nStefania Ragone\, Pharmaceutical Assessor\, Medicines & Healthcare Products Regulatory Agency (MHRA)\nTina Arien\, Principal Scientist\, Janssen Pharmaceutica\nVikas Jaitely\, Director\, Global Regulatory Affairs Transitional Medicine and Devices\, Merck\n\nLinkedIn: @SMi Pharma\nTwitter: @SMiPharm #SMiInjectables
URL:https://www.pharmajournalist.com/event/injectable-drug-delivery-2021/
LOCATION:St. James’ Court\, 54 Buckingham Gate\, Westminster\, London\, SW1E 6AF\, United Kingdom
ORGANIZER;CN="SMi Group":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
END:VCALENDAR